Introduction {#Sec1}
============

The prognostic value of slow heart rate recovery (HRR) after exercise in predicting cardiovascular disease (CVD) events has been established \[[@CR5], [@CR11], [@CR12], [@CR13], [@CR15]\]. Initial increases in heart rate with exercise are due to parasympathetic withdrawal while sympathetic activation is responsible for heart rates greater than a 100 beats/minute. In the first two minutes following cessation of exercise, the rapid decrease in heart rate is principally determined by parasympathetic reactivation \[[@CR1], [@CR8]\]. Although slow HRR is associated with less autonomic nervous system responsiveness, the underlying mechanisms linking slow HRR to increased cardiovascular morbidity are not well understood. It is possible that slow HRR is associated with a higher susceptibility for atherosclerosis. Prior studies of patients referred for cardiac angiography for suspected ischemic heart disease (IHD) suggest an association between slow HRR and higher atherosclerotic burden \[[@CR15]\]. Further, slow HRR has been observed to be associated with several risk factors for atherosclerosis \[[@CR2], [@CR3], [@CR10]\]. However, the relationship between HRR and atherosclerosis in the general population has not been studied using a prospective study design. In a cohort of healthy young adults, we investigated whether slow HRR following a graded exercise treadmill test (GXT) was associated with the presence of coronary artery calcium (CAC), a marker of subclinical atherosclerosis, when assessed 15 years later.

Methods and statistical analysis {#Sec2}
================================

The Coronary Artery Risk Development in Young Adults study (CARDIA) is a longitudinal study designed to investigate the origins of cardiovascular disease in young adulthood \[[@CR6]\]. Beginning in 1985, 5,115 African-American and Caucasian individuals \[(African-American (52%) and women (54%)\] ages 18--30 were recruited at sites in Birmingham, Alabama; Chicago, Illinois; Minneapolis, Minnesota; and Oakland, California. All participants gave informed consents prior to enrollment.

At baseline, a symptom-limited maximal GXT was administered using the Balke protocol \[[@CR14]\]. The test included nine 2-minute stages of increasing difficulty with participants encouraged to exercise to exhaustion, followed by a recovery period at a speed of 3.2 km/hour at 0% grade. HRR was defined as the difference between the maximum HR and HR at 2-minutes into recovery \[[@CR10]\]. Participants were ineligible for exercise testing if they were on cardioactive medications, had a resting systolic or diastolic pressure \>160 or \>100 mmHg, or were febrile at time of examination. The rate of energy expenditure for the completion GXT was estimated and reported in metabolic equivalents (METs), as previously described \[[@CR14]\]. Information on physical activity was collected by interview using a standardized questionnaire.

At the year 15 follow-up examination, returning participants (*n* = 3,043) underwent coronary artery computed tomography (CT) scanning for the measurement of CAC. Mean HRR did not differ between those who did and did not return to the year 15 examination (42.8 versus 42.5 bpm, respectively; *p* = 0.55). Details of the scanning procedures have been described elsewhere \[[@CR4]\]. Briefly, using standardized protocols, two scans were obtained for each participant (1--2 minutes apart) using electron beam CT scanners at the Chicago and Oakland sites and multidetector-row CT scanners at the Birmingham and Minneapolis sites. Calcium scores were calculated across each coronary artery and then summed across all the arteries. The final CAC score of positive scans was calculated as the mean of the two CAC scores obtained from each of the scans.

Participants were sequentially excluded from this analysis for the following reasons: use of medications that affect heart rate (HR) (*n* = 27), unavailable GXT or CAC data (*n* = 661), missing data on blood pressure, lipids, glucose, or smoking (*n* = 353), pregnancy (*n* = 27) or those absent at the year 15 exam (*n* = 1,399). Following exclusions, 2,648 participants remained.

Baseline characteristics were compared across sex-specific HRR tertiles. For continuous variables, test for linear trend was performed with HRR as a continuous variable using linear regression models. The Cochran-Armitage test was used to check for linear trend in binomial proportions across the HRR categories. Next, logistic regression was used to estimate the odds of the presence of CAC (defined as a CAC score \>0) in relation to year 0 HRR (independent variable). HRR was modeled both as a continuous variable and in tertiles (fastest HRR tertile as the reference). Statistical significance was determined at *P* \< 0.05. All analyses were conducted using SAS version 9.1 (SAS Institute Inc, Cary, NC).

Results {#Sec3}
=======

Demographic characteristics of the study sample, by 2-minute HRR tertiles, are presented in Table [1](#Tab1){ref-type="table"}. Mean 2-minute HRR (standard deviation) for men and women were 44.3 (11.4) and 41.7 (11.5) bpm, respectively. Participants with slower HRR had less favorable GXT performance characteristics, a higher resting heart rate (both at year 0 and year 15) and reported less physically activity (both at year 0 and year 15). Table 1Baseline characteristics according to tertiles of 2-minute heart rate recovery (N = 2,648)aBaselineBaseline sex-specific HRR tertiles1 (slow)23 (fast)P trendNumber of women479463521NANumber of men392391402NA*HRR (median \[min, max\])*Women31.0 (1.0, 36.0)41.0 (37.0, 45.0)51.0 (46.0, 116.0)NAMen34.0 (−6.0, 39.0)44.0 (40.0, 48.0)54.0 (49.0, 97.0)NAAge (years)25.4 (3.5)25.1 (3.6)25.0 (3.6)0.003African-American, *N* (%)360 (41.3)383 (44.9)435 (47.1)0.014Body Mass Index kg/m^2^24.9 (5.2)24.1 (4.2)23.8 (4.0)\<0.001Resting heart rate (bpm) at year 071.5 (11.4)69.3 (10.2)66.1 (9.7)\<0.001Resting heart rate (bpm) at year 1568.3 (10.8)68.2 (12.1)66.5 (11.3)\<0.001Maximum heart rate (bpm)180.1 (15.8)180.0 (14.6)181.0 (13.9)0.001Estimated METs at peak exercise11.8 (3.0)12.1 (2.7)12.5 (2.7)\<0.001Total physical activity score (exercise units) at year 0375.8 (273.0)428.6 (317.5)459.7 (307.3)\<0.001Total physical activity score (exercise units) at year 15325.4 (278.1)346.9 (288.0)382.4 (296.6)\<0.001^a^Values are expressed as mean (standard deviation) unless otherwise indicated. HRR = heart rate recovery. NA = not applicable. METs = metabolic equivalents

The prevalence of CAC in the study sample was 9.0% (*n* = 239). Mean HRR at year 0 did not differ between those who had positive CAC scores versus those who had a CAC score of 0 at year 15 (42.8 bpm, for both). The unadjusted odds ratio (OR) for having a CAC score \>0 for those in the slowest HRR tertile compared to those in the fastest HRR tertile was not significantly greater than 1.00 (Table [2](#Tab2){ref-type="table"}). Similar findings were observed when HRR was studied as a continuous variable. Table 2Unadjusted odds ratio (95% confidence interval) for the presence of coronary artery calcium (score \>0) at year 15 by baseline 2-minute heart rate recoveryTotal sampleCaucasian menCaucasian womenAfrican-American menAfrican-American women*Odds Ratio (95% CI) for threshold models based on HRR tertiles*Tertile 1 (slow)1.13 (0.81--1.57)0.90 (0.54--1.50)1.12 (0.53--2.33)1.11 (0.52--2.36)1.44 (0.60--3.49)Tertile 21.20 (0.87--1.66)0.90 (0.54--1.50)0.90 (0.41--2.01)1.55 (0.78--3.09)1.37 (0.57--3.32)Tertile 3 (fast)1.00 (Ref)1.00 (Ref)1.00 (Ref)1.00 (Ref)1.00 (Ref)*Odds Ratio (95% CI) for HRR as continuous variable*Per SD change in HRR^a^0.99 (0.87--1.13)1.04 (0.84--1.28)0.86 (0.65--1.15)0.95 (0.70--1.30)0.88 (0.60--1.27)HRR = heart rate recovery. CAC = coronary artery calcium. CI = confidence interval. SD = standard deviation ^a^SD of HRR was 11.5 bpm

In secondary analysis, similar findings were observed when the presence of higher CAC burden (defined as a score \>100 \[*n* = 34\]) was studied, as well as when quartiles or quintiles of 2-minute HRR were analyzed. Lastly defining HRR at 1-minute into recovery also did not result in any association between HRR and CAC.

Conclusion {#Sec4}
==========

Slower HRR in young adulthood is not associated with the presence of CAC when assessed 15 years later in middle age (average age 40 years). Moreover, mean HRR at baseline did not differ between those with and without measurable CAC at year 15. While previous studies have examined the relationship of HRR with CAD events this study is first to investigate the relationship of HRR with a measure of subclinical atherosclerosis.

Slow HRR has been associated with higher incident all-cause mortality, sudden cardiac death (SCD), and CVD events; however, the underlying mechanisms that link these relationships together are not known \[[@CR5]\]. Morshedi-Meibodi et al. \[[@CR12]\] using data from the Framingham Heart Study (FHS) observed slow HRR to be associated with coronary heart disease events (defined as acute coronary syndromes or SCD), suggesting a possible relationship between slow HRR and ischemic processes. Similarly, slow HRR has been observed to be associated with several risk factors for atherosclerosis \[[@CR2], [@CR3], [@CR10]\]. In contrast to findings from the FHS, Jouven et al. \[[@CR9]\] observed slow HRR to be related only to SCD and not death from myocardial infarction. Due to over lapping and discrepancy in clinical end points used in prior HRR studies, it cannot be determined whether slow HRR is associated with atherosclerosis or an increased susceptibility to lethal cardiac arrhythmias.

The ability of coronary CT to assess the global burden of atherosclerosis in young adults is uncertain, and CAC is only a subset of atherosclerosis, representing calcified plaques which tend to be more stable than their lipid-rich counterparts \[[@CR7]\]. Despite these limitations, our study suggests that slow HRR in young adulthood is not related to subclinical atherosclerosis at middle age, which supports the hypothesis that slow HRR is associated with mechanisms related to cardiac arrhythmia rather than atherosclerosis.
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